ExploreWatchlistsPricing
  1. JP-listed companies
  2. DAIICHI SANKYO COMPANY, LIMITED
  3. Financials
  4. Marketable securities, non-current

DAIICHI SANKYO COMPANY, LIMITED (4568)

Market cap
¥5.29T
P/E ratio
17.8x
Daiichi Sankyo is a global pharmaceutical company that researches, develops and sells prescription drugs and over-the-counter medicines worldwide.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndMarketable securities, non-current (Million JPY)YoY (%)
Mar 31, 2025139,175-5.90%
Mar 31, 2024147,906+13.43%
Mar 31, 2023130,393-0.85%
Mar 31, 2022131,509-6.06%
Mar 31, 2021139,991+42.89%
Mar 31, 202097,974-14.73%
Mar 31, 2019114,895+17.87%
Mar 31, 201897,475-7.71%
Mar 31, 2017105,618-20.58%
Mar 31, 2016132,979-76.24%
Mar 31, 2015559,771

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat